RF

Robert Figlin

4DMedical Limited | Non-Executive Director
Dr Figlin established and directs the Kidney Cancer Program at Cedars-Sinai Medical Center, which aims to understand the biology of kidney cancer and translate that knowledge into novel treatment approaches. His leadership is in novel anticancer drugs that avoid the toxicity associated with standard treatments and furthers Cedars-Sinai's tradition of patient care. He is the Chair of the Medical Advisory Committee.

Company and Role

Company
Title
Tenure
Since
4DX
4DX
4DMedical Limited
  • Non-Executive Director
9yrs, 10mthDec 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
4DX
4DX
4DMedical Limited
30/06/26882,840N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
4DX
4DX
4DMedical Limited
26/02/26
Buy
302,750$3.720$1,126,230Conversion of securities
4DX
4DX
4DMedical Limited
26/02/26
Exercise
302,750$3.720$1,126,230Conversion of securities
4DX
4DX
4DMedical Limited
15/12/25
Issued
302,750$0.400$121,250Director remuneration
4DX
4DX
4DMedical Limited
14/01/25
Exercise
60,147$0.520$31,276Conversion of securities
4DX
4DX
4DMedical Limited
14/01/25
Buy
60,147$0.520$31,276Conversion of securities